200 related articles for article (PubMed ID: 24994673)
1. Impact of 5-fluorouracil metabolizing enzymes on chemotherapy in patients with resectable colorectal cancer.
Ochiai T; Umeki M; Miyake H; Iida T; Okumura M; Ohno K; Sakamoto M; Miyoshi N; Takahashi M; Tsumura H; Tokunaga Y; Naitou H; Fukui T
Oncol Rep; 2014 Sep; 32(3):887-92. PubMed ID: 24994673
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
Yamada H; Iinuma H; Watanabe T
Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy.
Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsuruoka Y; Takahashi Y; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
J Surg Oncol; 2006 Jul; 94(1):45-50. PubMed ID: 16788943
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy.
Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
Int J Cancer; 2006 Jun; 118(12):3084-8. PubMed ID: 16425285
[TBL] [Abstract][Full Text] [Related]
5. Clinical role of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
Tokunaga Y; Sasaki H; Saito T
Surgery; 2007 Mar; 141(3):346-53. PubMed ID: 17349846
[TBL] [Abstract][Full Text] [Related]
6. Correlation between clinical pathologic factors and activity of 5-FU-metabolizing enzymes in colorectal cancer.
Yamada T; Tanaka N; Yokoi K; Seya T; Kanazawa Y; Koizumi M; Ohaki Y; Tajiri T
J Nippon Med Sch; 2008 Feb; 75(1):23-7. PubMed ID: 18360075
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of thymidylate synthetase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activity levels in colorectal carcinoma following radical resection and administration of adjuvant 5-FU chemotherapy.
Ishikawa M; Miyauchi T; Kashiwagi Y
BMC Cancer; 2008 Jul; 8():188. PubMed ID: 18597678
[TBL] [Abstract][Full Text] [Related]
8. Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
Ichikawa W; Uetake H; Shirota Y; Yamada H; Takahashi T; Nihei Z; Sugihara K; Sasaki Y; Hirayama R
Br J Cancer; 2003 Oct; 89(8):1486-92. PubMed ID: 14562021
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
[TBL] [Abstract][Full Text] [Related]
10. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
11. Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU.
Isshi K; Sakuyama T; Gen T; Nakamura Y; Kuroda T; Katuyama T; Maekawa Y
Int J Clin Oncol; 2002 Dec; 7(6):335-42. PubMed ID: 12494248
[TBL] [Abstract][Full Text] [Related]
12. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
[TBL] [Abstract][Full Text] [Related]
13. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma.
Fujii R; Seshimo A; Kameoka S
Int J Clin Oncol; 2003 Apr; 8(2):72-8. PubMed ID: 12720098
[TBL] [Abstract][Full Text] [Related]
14. Correlations of clinicopathological factors with protein expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in colorectal cancer.
Sumi T; Katsumata K; Tsuchida A; Ishizaki T; Shimazu M; Aoki T
Chemotherapy; 2010; 56(2):120-6. PubMed ID: 20407238
[TBL] [Abstract][Full Text] [Related]
15. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
Ishida H; Shirakawa K; Ohsawa T; Sobajima J; Hayashi Y; Nakada H; Yokoyama M; Hashimoto D
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1929-34. PubMed ID: 16282729
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Kihara A; Okano M
Gan To Kagaku Ryoho; 2001 May; 28(5):661-7. PubMed ID: 11383215
[TBL] [Abstract][Full Text] [Related]
17. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.
Hahnvajanawong C; Chaiyagool J; Seubwai W; Bhudhisawasdi V; Namwat N; Khuntikeo N; Sripa B; Pugkhem A; Tassaneeyakul W
World J Gastroenterol; 2012 Aug; 18(30):3955-61. PubMed ID: 22912546
[TBL] [Abstract][Full Text] [Related]
18. The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.
Oeda M; Yoshida K; Sanada Y; Wada Y; Suzuki T; Mizuiri H; Konishi K; Shigematsu H; Tanabe K; Fukushima M
Oncol Rep; 2006 Dec; 16(6):1165-72. PubMed ID: 17089033
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y
Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
